Jason K. Garland

Jason K. Garland is a declared insider at 3 companies (finance chief); the most frequent names are Repligen Corp, Integer Holdings Corp and Acutus Medical, Inc. We count 18 filings; the first trade dates from 2 October 2021 and the latest from 25 September 2026.

No open-market purchase appears, only 2 sales worth €69k. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 12 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The latest filing, published on 28 September 2026, reports a share grant of €70k in Repligen Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.